A short course of immunotherapy prior to surgery was highly effective in treating colon cancer, with 95% of patients showing significant tumor reduction or complete elimination. The treatment also showed promising results in preventing cancer recurrence and metastasis over a two-year follow-up period.
Scientists at Gladstone Institutes developed two new tools for single-molecule analysis, slashing the amount of DNA needed by 90 to 95 percent. The SMRT-Tag tool allows researchers to study DNA at single-molecule resolution using as few as 10,000 cells, enabling the analysis of tumor biopsies and other clinically relevant samples.
A team of researchers at University of California San Diego has identified a biochemical mechanism that can interrupt cellular communication chains, disrupting the signaling pathways related to many diseases. The discovery highlights the importance of growth factors and G protein-coupled receptors in cell signaling.
A Phase III trial led by the University of Texas M. D. Anderson Cancer Center found proton therapy to be non-inferior to traditional radiation therapy in treating head and neck cancer. The study revealed a significant reduction in malnutrition and feeding-tube dependency with proton therapy.
A cohort study found that decentralization through telemedicine and local care can substantially reduce cancer care's environmental impact. The study also showed small reductions in human mortality as a result of these changes.
A new immunotherapy approach employs a two-pronged attack against solid tumors to boost the immune system's ability to target and eliminate cancer cells. By combining CV1-producing T cells with cancer-targeting antibodies, researchers improved macrophage consumption of tumor cells, suggesting a potential solution to treatment challenges.
A quality improvement analysis found that many US residents live within 30 miles of a clinical trial site, highlighting disparities in access. The study highlights concerns about equity and fairness in healthcare resource distribution, particularly for marginalized communities.
A study led by Washington State University scientists found that inhibiting CDK7 could help prevent heart damage associated with doxorubicin, a commonly used cancer chemotherapy medication. The researchers also discovered that CDK7 inhibition enhances the medication's cancer-killing capability.
A new study reveals that a type of childhood leukemia has its roots in fetal development, with chromosomal alterations detected in umbilical cord blood. The findings have important implications for understanding the disease and developing new therapies.
A genomic study uncovers germline ARID1B and mitochondrial variants that may drive pediatric chordoma genesis, a rare and aggressive bone tumor. The study found aberrant indels and haywire mitochondria in 22% of pediatric chordoma samples.
Active surveillance for favorable-risk prostate cancer demonstrated to be a safe and effective management strategy, with less than 2% developing metastatic disease. The study found no significant association between delayed treatment during surveillance and worse outcomes.
Scientists at Gladstone Institutes used CRISPR interference to map the layered mechanisms controlling expression of key immune genes. The study provides valuable insights into immune balance, autoimmunity, and cancer immunotherapies, shedding light on genetic variants linked to disease risk and potential treatments.
A new type of immunotherapy has been developed to treat bone cancer osteosarcoma, with promising preclinical results in mice. The treatment uses gamma-delta T cells, which are less well-known immune cells that can be engineered to target tumours.
Research highlights varied associations between social isolation and mortality risk across demographic groups, including socioeconomic disparities. The study emphasizes the importance of considering sociodemographic heterogeneity in understanding the impact of social isolation on health outcomes.
Researchers aim to develop FLASH radiotherapy for treating skin cancer, rectal cancer and sarcomas with fewer side effects and less damage to healthy tissues. The project focuses on calibrating equipment and conducting lab studies to apply the technique safely and effectively in clinical settings.
Researchers have developed an approach to 'delete' a diseased blood system while building up a new, healthy one with donor blood stem cells. This process involves targeting specific antibodies coupled to a cytotoxic drug that recognize and destroy diseased blood cells while sparing healthy ones.
A Kaiser Permanente study of 316,443 patients reveals that 7.4% repeated fecal testing instead of proceeding to a colonoscopy, and only 41% received a colonoscopy within one year of their initial positive test. Patients who repeated home tests cited concerns about colorectal cancer diagnosis
Researchers found that up to one in seven melanoma patients carry cancer susceptibility genes, suggesting family history may be a bigger risk factor than previously thought. This discovery supports the idea that there are risk factors beyond sun exposure that can influence an individual's chances of developing melanoma.
At NUTRITION 2024, researchers will explore emerging findings on the role of diet in cancer risk and survivorship, as well as personalized dietary therapy for cancer treatment and survivorship. Scientists will also share insights into precision nutrition, environmental sustainability, and infant feeding practices, shedding light on the...
A new type of immune cell, MR1T cells, has been found to detect cancer cells through metabolic traces. This discovery opens up new avenues for targeted therapies against various types of cancer. The cells recognize altered metabolism in cancer cells, which produces specific molecules on the surface.
Researchers at Lawrence Berkeley National Laboratory identified 28 trace metals in secondhand and thirdhand tobacco smoke, including cadmium, arsenic, and chromium. The study found that the predicted indoor air concentration for these metals exceeded California's cancer risk guidelines, highlighting the need to understand their contrib...
A cross-sectional study reveals racial and ethnic disparities in treatment delays and discontinuations among patients with SARS-CoV-2, leading to increased cancer mortality among minoritized adults. The disproportionate burden varied across SARS-CoV-2 waves.
Cases of gallbladder cancer have been steadily increasing among non-Hispanic Blacks in the US, with growing numbers diagnosed at later stages. The incidence of late-stage tumors has also risen, contributing to a higher mortality rate compared to other racial and ethnic groups.
Studies reveal distinct differences in oral microbiomes of patients with gastric cancer, premalignant conditions, and healthy controls. Researchers also found a surge in colorectal cancer incidence among young patients under 45, while late-stage gallbladder cancer is on the rise in non-Hispanic Blacks.
Adult carriers of BAP1 tumor predisposition syndrome show a high incidence of onychopapillomas, a benign nail tumor. This finding suggests using these skin abnormalities to identify family members and patients with cancers associated with the syndrome.
Nach0 was trained on diverse tasks, including natural language understanding, synthetic route prediction, and molecular generation. The model performed well on molecular tasks using molecular data and outperformed ChatGPT, making it a significant step toward unlocking the full potential of LLMs for drug discovery.
Global life expectancy is forecasted to increase from 73.6 years in 2022 to 78.1 years in 2050, with a convergence of increased life expectancy across geographies. The trend is largely driven by public health measures that have prevented and improved survival rates from cardiovascular diseases, COVID-19, and other communicable diseases.
Researchers used AI to detect localized versus advanced cancer stages in oropharyngeal squamous cell carcinoma patients. The study suggests improved patient care and clinical decision-making through AI-assisted health record extraction.
A study published in JAMA Oncology found that AI chatbots can generate empathetic and readable responses to cancer patient questions, comparable to those from physicians. The research also highlights the need for further investigation into the scope, process integration, and patient outcomes of chatbot-facilitated interactions.
A team of researchers from NUS has developed a novel method to stimulate muscle cells using magnetic therapy, which produces and releases proteins with anticancer properties. The study demonstrates that this non-invasive approach can prevent cancer cell growth and invasion, similar to exercise.
Insilico Medicine's lead compound demonstrates strong enzymatic activity, selectivity, and favorable ADME properties, as well as antitumor activity in various animal models. The company's generative AI-powered platform generated over 3,600 candidate molecules before identifying the promising lead compound.
A groundbreaking study has revealed that the centromere consists of two subdomains, which play a crucial role in ensuring proper chromosome segregation during cell division. This discovery provides new insights into the mechanisms underlying erroneous divisions in cancer cells.
Researchers at Goethe University Frankfurt have discovered thalidomide derivatives that target and degrade BCL-2, a protein essential for the survival of cancer cells. The derivatives bind to CRBN, reprogramming its binding surface to mark BCL-2 for degradation, ultimately leading to cell death.
A recent study found that American firefighters recognize the link between diet and cancer risk and are interested in acquiring knowledge and support to change their dietary habits. The study suggests that targeted interventions focusing on individualized support and evidence-based interventions can help mitigate cancer risks among fir...
A UK Biobank study suggests that adults living with obesity who were underweight or average weight in childhood may be at increased risk of all-cause mortality. The study found that adult men and women who reported being thinner as children had higher mortality risks, with a 63% and 60% increase respectively.
Researchers have developed a breakthrough therapy that can adapt CAR-T cell therapy to target solid tumors, potentially transforming cancer treatment. The therapy uses a novel antibody and costimulatory protein to activate T cells, overcoming the challenges of immune suppression in solid tumors.
A new study found that PARP1 is involved in the repair of telomeres, which can lead to genomic instability and cancer. Impairing this process can lead to telomere shortening and increased risk of cancer. The findings challenge existing dogma and open up new possibilities for improving cancer therapies.
Young survivors of childhood cancer experience prevalent symptoms years after diagnosis. Interventions to reduce caregiver anxiety and neighborhood adversity may alleviate symptom burden.
Researchers developed a predictive model, TRTpred, to identify the most potent cancer killing immune cells using artificial intelligence. The model achieved 90% accuracy in identifying tumor-reactive T cells and can be applied to personalized cancer treatments.
Substantial geographic disparities in cancer clinical trials availability exist in the US, with socially vulnerable counties facing significant limitations. The disparity has worsened over time, with these counties often having fewer trial options available.
Researchers employ a geology tool to analyze hydrogen atoms in cancer cells, finding a distinct ratio compared to healthy tissue. This discovery may lead to new ways to spot cancer early on and inform strategies for studying its growth and spread.
Researchers at UC San Diego developed a machine learning algorithm to simulate chemistry in drug discovery, synthesizing 32 potential multi-target cancer drugs. The new AI platform, POLYGON, can identify molecules with multiple targets, potentially delivering more effective treatments with fewer side effects.
The article assesses Community Outreach and Engagement initiatives at NCI-DCCs, highlighting successful programs that reduced disparities. The authors emphasize the need for sustained focus on community outreach and engagement, clinical access, and health equity to ensure everyone has access to latest scientific advances.
Researchers developed an in-situ cancer vaccine that targets mutated proteins on cancer cells and triggers immunity. The vaccine was combined with chemotherapy, increasing survival rates in AML patients.
Scientists at Umeå University have identified how a protein complex called the Mediator regulates gene expression, leading to slower cell division. This discovery may pave the way for new treatments for diseases related to uncontrolled cell growth, such as tumors.
The American Society for Nutrition's NUTRITION 2024 will bring together thousands of experts to share emerging scientific and policy developments in food, nutrition, and public health. Over 1,600 original research studies will be presented during the meeting.
A new study reveals that chronic hepatitis B is globally undertreated, especially among women and Asian minorities in the West. The research highlights the need for targeted outreach to reduce new infections and deaths, with oral antiviral therapy being a lifesaving but underutilized treatment option.
A new study uncovers obscured contributions to microbiome biomarkers in colorectal cancer development, highlighting potential future targets for intervention. The research employs quantitative methods and extensive confounder control to reveal robust associations between certain microbial taxa and CRC.
A University of California - Riverside study finds that medium-sized dogs have a higher risk of developing cancer than larger or smaller breeds. The multistage model of cancer acquisition supports this finding, suggesting that size is a major risk factor for cancer.
Researchers at Insilico Medicine developed COSMIC, a new framework for molecular conformation space modeling that provides accurate insights into molecule positioning and activity. This enables faster and more efficient drug design decisions.
A recent study published in BJSM found that increased cardio fitness level can reduce the risk of death from any cause and heart disease by 11-17% and 18%, respectively. Regular aerobic exercise programs can achieve this, leading to a reduced risk of early death and chronic conditions.
Increased vitamin D bioavailability leads to changes in the microbiome favoring Bacteroides fragilis, enhancing immune-mediated resistance to cancer. Fecal transplantation transfers this anti-cancer immunity to other mice.
Researchers at TUM have uncovered a mechanism by which tumor cells prevent the formation of immune responses, including cytotoxic T cells. This discovery provides rationales for new cancer immunotherapies and could enhance existing treatments.
A recent study revealed that phosphoinositide 3-kinase (PI3K) has a built-in brake mechanism that impedes cell migration, while also acting as an accelerator to prompt motility. The brake mechanism is specific to the p85β subunit and can be disrupted, leading to uncontrolled cell movement.
Researchers discovered that prostaglandin E2 (PGE2) undermines the anti-cancer immune response and compromises adoptive cell therapy using tumor infiltrating lymphocytes. Disrupting PGE2's mechanism improves therapeutic potential of transferred TILs in mouse models of cancer.
A new clinical trial reveals that a novel writing therapy can significantly reduce cancer-related trauma, depression, anxiety, and hopelessness in late-stage cancer patients. By confronting their greatest fears through written exposure-based coping (EASE), participants experience improved mental well-being.
Researchers developed a novel way to localize cancer-killing cytokines in tumors to improve treatment effectiveness. The approach ensures that immune cell-stimulating cytokines remain within the tumor for weeks, reducing toxicity to healthy cells.
Only 4% of cancer survivors met all four American Cancer Society guidelines, with a mean of 2.0 guidelines met. This study aims to improve understanding of guideline adherence and inform recommendations for patients who have completed cancer treatments.
Researchers have developed a new urine-based test that identifies high-grade prostate cancer by analyzing 18 genes linked to the disease. The test, called MyProstateScore2.0, was shown to be nearly 100% correct at ruling out aggressive cancers and helped avoid up to 41% of unnecessary biopsies.
Researchers argue that among adults who have tried FDA-approved cessation medicines, switching to e-cigarettes may be a better option due to lower health risks. E-cigarette products authorized by the FDA are considered less harmful than combustible cigarettes.